Filter by
News (54)
RSS
Dr Michael Makanga, Executive Director of Global Health EDCTP3, has been awarded a Special Career Achievement Prize of the Prix Galien Africa 2025 in recognition of his exceptional leadership in medical research and his role in amplifying the African voice on the global stage.
When speed meets experience: emergency funding builds on past Mpox research
Global Health EDCTP3 has joined other leading research funders in endorsing the Joint statement on strengthening clinical trials 2025
BioNTech partners with Global Health EDCTP3 to support African research
Safer beginnings for every child
A new wave of research and innovation is officially underway in Europe and sub-Saharan Africa, as the 29 projects selected under the 2024 Global Health EDCTP3 calls for proposals have now begun their work.
A promising and much-needed tuberculosis (TB) treatment is advancing through clinical trials thanks to support from European partnerships IMI2 and EDCTP.
Global Health EDCTP3 has received 104 applications by the 3 September second-stage deadline for the 2025 calls. Applicants have requested nearly €666.5 million in Global Health EDCTP3 funding, against the indicative call budget of €239.8 million.
The CHAPAS consortium: pioneers in HIV treatment for children
Professor Harleen Grewal has taken over as the new Chairperson of the Scientific Committee, as new members have assumed their duties over the past few months.